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Abstract
Toll like receptors play an important role in lung host defense against bacterial pathogens. In this study, we investigated
independent and cooperative functions of TLR4 and TLR9 in microbial clearance and systemic dissemination during
Gram-negative bacterial pneumonia. To access these responses, wildtype Balb/c mice, mice with defective TLR4 signaling
(TLR4
lps-d), mice deficient in TLR9 (TLR9
2/2) and TLR4/9 double mutant mice (TLR4
lps-d/TLR9
2/2) were challenged with K.
pneumoniae, then time-dependent lung bacterial clearance and systemic dissemination determined. We found impaired
lung bacterial clearance in TLR4 and TLR9 single mutant mice, whereas the greatest impairment in clearance was observed
in TLR4
lps-d/TLR9
2/2 double mutant mice. Early lung expression of TNF-a, IL-12, and chemokines was TLR4 dependent, while
IFN-c production and the later expression of TNF-a and IL-12 was dependent on TLR9. Classical activation of lung
macrophages and maximal induction of IL-23 and IL-17 required both TLR4 and TLR9. Finally, the i.t. instillation of IL-17
partially restored anti-bacterial immunity in TLR4
lps-d/TLR9
2/2 double mutant mice. In conclusion, our studies indicate that
TLR4 and TLR9 have both non-redundant and cooperative roles in lung innate responses during Gram-negative bacterial
pneumonia and are both critical for IL-17 driven antibacterial host response.
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Introduction
Pneumonia is a leading infectious cause of mortality in
immunocompetent individuals in the United States. Klebsiella
pneumoniae is a Gram negative bacteria that is a well described
cause of both community acquired and hospital acquired
pneumonia [1]. Mortality in pneumonia caused by K. pneumoniae
is due to propensity for early systemic bacterial dissemination
resulting in sepsis, and the development of acute lung injury [2].
Early clearance of the pathogen from the lung is required to
prevent Klebsiella pneumonia associated complications [3].
Toll like receptors (TLRs) are a family of type I transmem-
brane receptor proteins that are required for the recognition of
various pathogen-associated molecular patterns expressed by a
diverse group of infectious microorganisms, resulting in the
activation of host immune responses [4]. For example, TLR4 has
been shown to be required for effective innate immunity against
selected extracellular Gram-negative pathogens, including Hae-
mophilus influenza, Eschericia coli and Klebsiella pneumoniae [5,6,7].
However, although innate signals produced early (at 4 h) in
response to challenge with K. pneumoniae are markedly diminished
in mice with defective TLR4 signaling, later responses (at 16 h)
remain largely intact [5]. TLR9 has also been shown to be
important for innate host defense against Gram-negative
bacteria, including Klebsiella and Neisseria [8,9]. Mice lacking
TLR9 display impaired bacterial clearance when challenged with
K. pneumoniae i.t., which is associated with reduced dendritic cell
recruitment and activation, decreased type 1 cytokine expression,
and alternative rather than classical activation of lung macro-
phages [8]. Importantly, host innate responses against both
extracellular and intracellular bacterial pathogens are more
dramatically impaired in mice that lack the common adaptor
molecule MyD88 than in mice that are deficient in a single TLR
(e.g., TLR2 or TLR4), suggesting cooperativity of various TLRs
or the involvement of other MyD88-dependent TLRs [10,11].
Collectively, these data indicate that multiple MyD88-dependent
TLRs are required for the maintenance and/or full expression of
protective innate responses during Gram-negative bacterial
pneumonia.
To further investigate potential interactive role of TLRs in
generating host defense in the lung during Gram-negative
infection, we assessed innate antibacterial responses to i.t. K.
pneumoniae challenge in mice with defective TLR4 signaling
(TLR4
lps-d), mice deficient in TLR9 (TLR9
2/2) and double
mutant mice (TLR4
lps-d/TLR9
2/2). We observed that maximal
classical activation of lung macrophages, expression of IL-23 and
IL-17, and lung bacterial clearance required cooperative interac-
tions between TLR4 and TLR9, whereas survival responses in
mice challenged with K. pneumoniae were largely dictated by the
presence or absence of functional TLR4.
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Reagents
Murine recombinant IL-17A for i.t. reconstitution experiments
was purchased from R&D Systems (Minneapolis, MN).
Mice
Female Balb/c (National Cancer Institute-Harlan, Frederick,
MD) were used at 8 to 12 weeks of age. Breeding pairs of TLR9
2/2
mice generated by S. Akira (Osaka, Japan) were obtained from
Coley Pharmaceutical (Wellesley, MA) and a colony established at
the University of Michigan. These mice were generated on a Balb/c
background (.8 backcrosses), are phenotypically normal in the
uninfected state, and reproduce without difficulty. Breeding pairs of
mice with defective TLR4 signaling and bred onto a Balb/c
background (TLR4
lps-d) were obtained from Jackson Laboratories
and a breeding colony established. TLR4
lps-d mice were then
crossed with TLR9
2/2 to generate TLR4
lps-d/TLR9
2/2 double
mutant mice. All animals were handled in strict accordance with
good animal practice as defined by the relevant national and/or
local animal welfare bodies, and all animal work was approved by
the UCUCA(University Committee on Use and Care of Animals)
committee at the University of Michigan.
K. pneumoniae inoculation
K. pneumoniae strain 43816 serotype 2 (American Type Culture
Collection) was used in our studies. K. pneumoniae was grown
overnight in tryptic soy broth (Difco) at 37uC and quantitated
using spectrophotometry [12]. For i.t. administration, mice were
anesthetized with an i.p. ketamine and xylazine mixture. Next, the
trachea was exposed and 30 ml of inoculum was administered via a
sterile 26-gauge needle. The skin incision was closed using surgical
staples.
Lung harvesting for bacterial number, and cytokine
analyses
At designated time points, mice were euthanized by CO2
asphyxia. Prior to lung removal, the pulmonary vasculature was
perfused with 1 ml of phosphate-buffered saline (PBS) containing
5 mM EDTA via the right ventricle. Whole lungs were then
harvested for assessment of bacterial CFU and cytokine protein
expression. After removal, lungs were homogenized in 1 ml of PBS
with protease inhibitor (Boehringer Mannheim Biochemicals,
Indianapolis, Ind.) using a tissue homogenizer (Biospec Products,
Inc.) under a vented hood. Aliquots of homogenates (10 ml) were
inoculated on nutrient agar after serial 1:10 dilutions with PBS.
The homogenates were incubated on ice for 30 min and then
centrifuged at 1,1006g for 10 min. Supernatants were collected,
passed through a 0.45-mm-pore-size filter (Gelman Sciences, Ann
Arbor, Mich.), and stored at 20uC for assessment of cytokine
levels.
Bronchoalveolar lavage
Bronchoalveolar lavage (BAL) was performed at various time
points post i.t. administration of bacteria. Briefly, the trachea was
exposed and intubated using a 1.7-mm outer diameter polyeth-
ylene catheter. BAL was performed by instilling PBS containing
5 mM EDTA in 1 ml aliquots for a total of 3 mls. Lavaged cells
were counted, cytospins performed and alveolar macrophages
were harvested after adherence purification and cultured for
1 hour. Supernatants were collected and analyzed by ELISA for
cytokine production and the cells were harvested for mRNA
expression by real time PCR.
Total lung leukocyte preparation
Lungs were removed from euthanized animals, and leukocytes
were prepared as previously described [6,11]. Briefly, lungs were
minced with scissors to a fine slurry in 15 ml of digestion buffer
[RPMI medium/10% fetal calf serum/1 mg/ml collagenase
(Boehringer Mannheim Biochemical)/30 mg/ml DNase (Sigma)]
per lung. Lung slurries were enzymatically digested for 30 min at
37uC. Any undigested fragments were further dispersed by
drawing the solution up and down through the bore of a 10-ml
syringe. The total lung cell suspension was pelleted, resuspended,
and spun through a 40% Percoll gradient to enrich for leukocytes.
Cell counts and viability were determined using trypan blue
exclusion counting on a hemacytometer. Cytospin slides were
prepared and stained with a modified Wright-Giemsa stain.
Flow cytometry for intracellular IL-17 expression
Cells were isolated from lung digests as described above. For
analysis of T cell subsets, isolated leukocytes were stained with the
following FITC- or PE-labeled anti-cd TCR anti-CD4 (BD
Pharmingen). In addition, cells were stained with anti-CD45-
tricolor (Caltag Laboratories), allowing for the discrimination of
leukocytes from nonleukocytes and thus eliminating any nonspe-
cific binding of T cell surface markers on nonleukocytes. Cells
were then fixed and permeabilized using BD cytofix/cytoperm
fixation/permeabilization kit for 20 min on ice. After washing,
cells were stained for intracytoplasmic IL-17A expression with PE
conjugated rat anti-mouse IL-17A Ab (BD Pharmingen) diluted in
wash solution for 30 min. T cell subsets were analyzed by first
gating on CD45-positive ‘‘lymphocyte-sized’’ leukocytes and then
examined for FL1 and FL2 fluorescence expression using three
color flow cytometry. Cells were collected on a FACScan or
FACScalibur cytometer (BD Biosciences) by using CellQuest
software (Becton Dickinson). Analyses of data were performed
using the CellQuest software package.
Isolation and culture of bone marrow-derived dendritic
cells
Bone marrow was harvested from the long bones of mice using a
previously described technique[8]. Recovered marrow cells were
seeded in tissue culture flasks in RPMI 1640 based complete media
with murine GM-CSF (10 ng/ml). Media and cytokines were
replaced after 3 days, loosely adherent cells collected after 6–7
days and cells positively selected for CD11c+ by magnetic bead
separation. CD11c+ DC were plated overnight and resuspended
in fresh media the following day. Flow cytometry of cells verified
.90% purity for DC. BMDC were cultured at a concentration of
5610
5 cells/ml, incubated with vehicle or heat-killed K. pneumoniae
(10:1 MOI), then supernatants harvested 16 hrs later.
Expression of iNOS and Fizz-1 by alveolar macrophages
To assess spontaneous inducible nitric oxide synthase (iNOS)
and Fizz-1 expression in alveolar macrophages, cells were isolated
from lungs of WT and mutant mice post i.t. Klebsiella challenge by
BAL and alveolar macrophages isolated by adherence purification
and cultured for 1 hour at a concentration of 122610
6 cells/well.
Cells were washed X 3, then RNA immediately isolated.
Murine cytokine ELISAs
Murine TNF-a, KC/CXCL1, MIP-2/CXCL2, IL-12 p70,
IFN-c, IL-23 and IL-17 (R&D Systems, Minneapolis, MN) were
quantitated using a modification of a double-ligand method as
previously described [6,11]. The ELISA method used consistently
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ELISAs did not cross-react with other cytokines tested. [13]
Real-time quantitative RT-PCR
Measurement of gene expression was performed utilizing the ABI
Prism 7000 sequence detection system (Applied Biosystems, Foster
City, CA) as previously described [6]. Primers and probe nucleotide
sequences for miNOS, forward 59- CCC TCC TGA TCT TGT
GTT GGA-39, reverse 59-CAA CCC GAG CTC CTG GAA-39,
and probe 59-TGA CCA TGG AGC ATC CCA AGT ACG AGT-
39; for m-actin: forward 59-CCG-TGA-AAA-GAT-GAC-CCA-
GAT-C-39, reverse 59-CAC-AGC-CTG-GAT-GGC-TAC-GT-39,
probe 59-TTT-GAG-ACC-TTC-AAC-ACC-CCA-GCC-A-39, for
Fizz-1 forward 59- CCC TGC TGG GAT GAC TGC TA-39,
reverse 59-TCC ACT CTG GAT CTC CCA AGA -39 and probe
59- TGG GTG TGC TTG TGG CTT TGC -39. Specific thermal
cycling parameters used with the TaqMan One-Step RT-PCR
Master Mix Reagents kit included 30 min at 48uC, 10 min at 95uC,
and 40 cycles involving denaturation at 95uC for 15 seconds,
annealing/extension at 60uC for 1 min. Relative quantification of
cytokine mRNA levels was plotted as fold-change compared to
untreated control lung. All experiments were performed in
duplicate.
Statistical analysis
Survival curves were compared using the log-rank test. For
other data, statistical significance was determined using the
unpaired t test or one-way ANOVA corrected for multiple
comparisons as appropriate. All calculations were performed using
the Prism 3.0 software program for Windows (GraphPad
Software). All mean data shown are expressed as means 6 SEM.
Results
Survival in WT, TLR4
lps-d, TLR9
2/2 and TLR4
lps-d/TLR9
2/2
double mutant mice after K. pneumoniae administration
We and others have previously shown that both TLR4 and
TLR9 play a critical role in host defense during Klebsiella
pneumonia [5,8,14]. While the role of individual TLRs has been
studied, the relative contribution and potential interactions
between TLRs is unknown. For that reason, we administered K.
pneumoniae 8610
2 CFU i.t. to WT, TLR4
lps-d, TLR9
2/2 and
TLR4
lps-d/TLR9
2/2 double mutant mice, then assessed survival
out to 10 days. As shown in Figure 1, TLR9
2/2 mutant mice died
more quickly and had reduced long term survival, as compared to
WT mice (45% vs 85%, p,0.05). More impressively, all TLR4
lps-d
single mutant and TLR4
lps-d/TLR9
2/2 double mutant mice died,
with mortality observed as early as 48 hrs post Klebsiella
administration and no animals surviving past 3 days.
Bacterial clearance in WT, TLR4
lps-d, TLR9
2/2 and TLR4
lps-d/
TLR9
2/2 double mutant mice after K. pneumoniae
administration
Having observed decreased survival in single and double
mutants challenged with i.t. Klebsiella, we next explored the
mechanism accounting for reduced survival. WT, TLR4
lps-d,
TLR9
2/2 and TLR4
lps-d/TLR9
2/2 double mutant mice were
challenged with 5610
2 CFU i.t. K. pneumoniae i.t., then lungs and
blood harvested 6, 24 or 48 hours later. At 24 hours, we found
that both TLR4
lps-d and TLR9
2/2 mice challenged with K.
pneumoniae i.t. displayed evidence of impaired lung bacterial
clearance, as compared to WT mice [90 and 65 fold increase in
CFU over WT, respectively, (Figure 2A, p,0.05)]. Double mutant
(TLR4
lps-d/TLR9
2/2) mice had an even greater defect in lung
bacterial clearance, as compared to single mutant animals
(p,0.05), with a 300-fold increase in CFU as compared to
infected WT animals. No bacteremia was observed in any group
by 6 hrs post bacterial challenge. However, by 24 hrs bacteremia
was observed in all mutant mice, with blood CFU greatest in
TLR4
lps-d single mutant and TLR4
lps-d/TLR9
2/2 double mice.
By 48 hrs (Figure 2B), all mutant mice (TLR9
2/2, TLR4
lps-d,
TLR4
lps-d/TLR9
2/2) had statistically higher lung bacterial
burden as compared to the WT mice, (53, 309, and 560 fold
increase in CFU over WT mice, respectively, p,0.05). Mutant
mice also had higher bacterial counts in blood, with the TLR4
lps-d
and TLR4
lps-d/TLR9
2/2 double mutant mice having the highest
bacteremic burden (704-fold and 523-fold, respectively, as
compared to the WT mice). The TLR9
2/2 also had statistically
higher blood CFU (44-fold increase, as compared to the WT
mice).
Lung inflammatory cell influx in WT, TLR4
lps-d, TLR9
2/2
and TLR4
lps-d/TLR9
2/2 double mutant mice after K.
pneumoniae administration
To assess the role of TLRs in lung leukocyte influx, we
quantitated inflammatory cells in the lung digests of WT,
TLR4
lps-d, TLR9
2/2 and TLR4
lps-d/TLR9
2/2 double mutant
Figure 1. Survival after i.t. Klebsiella challenge in WT, TLR4
lps-d, TLR9
2/2, and TLR4
lps-d/TLR9
2/2 mice. n=12 in each group. *p,0.01 as
compared to WT mice. #p,0.01 as compared to TLR9
2/2 mice. Combined from 2 separate experiments.
doi:10.1371/journal.pone.0009896.g001
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challenge resulted in an early increase in total lung leukocytes in
WT mice by 6 hrs, which was largely due to an increase in
polymorphonuclear leukocytes (PMN). As compared to WT
infected animals, TLR4
lps-d and TLR4
lps-d/TLR9
2/2 mice dis-
played significantly lower numbers of lung PMN at this time point
(Table 1). By comparison, numbers of total leukocytes and PMN in
infected TLR9
2/2 mice did not significantly differ from similarly
treated WT animals. By 24 hrs post K. pneumoniae administration, no
differences in total leukocytes or PMN were observed in any of the
groups examined. Additionally, no differences in numbers of lung
monocyte/macrophages, CD4+ or CD8+ T cells was observed at 6
or24 hrsinthefourgroupsexamined(Table1anddatanotshown).
Lung cytokine production in WT, TLR4
lps-d, TLR9
2/2 and
TLR4
lps-d/TLR9
2/2 double mutant mice after
K. pneumoniae administration
Tumor necrosis factor-alpha (TNF-a), chemokines, type 1
cytokines (IL-12, IFN-c), and the Th17 cytokine IL-17 have been
shown to be critically important cytokine mediators of innate
antibacterial host responses in the lung [15]. To determine
whether impaired localized expression of these cytokines could
contribute to the increased bacterial burden observed in TLR
single and double mutant mice, levels of TNF-a, KC/CXCL1,
MIP-2/CXCL2, IL-12 p70, IFN-c, and IL-17 were quantitated in
lung homogenates by ELISA at 6 and 24 hrs post K. pneumoniae
administration. As shown in Figure 3, bacterial administration to
WT mice resulted in a rapid increase in the expression of all six
cytokines by 6 hrs, with declining levels of TNF-a, IL-12 and IFN-
c at 24 hrs, while the expression of KC/CXCL1, MIP-2/CXCL2
and IL-17 continued to increase out to 24 hrs. The production of
TNF-a was reduced in all mutant mice at 6 and 24 hrs. By
comparison, the levels of IL-12 were decreased at both 6 and
24 hrs in TLR4
lps-d, TLR4
lps-d/TLR9
2/2 mice, whereas late but
not early IL-12 production was reduced in mice deficient in
TLR9. KC/CXCL1 and MIP-2/CXCL2 production were
reduced in both infected TLR4
lps-d and TLR4
lps-d/TLR9
2/2
mice, but not significantly affected in mice deficient in TLR9,
compared to WT animals. IFN-c production was significantly
decreased in TLR9
2/2 and TLR4
lps-d/TLR9
2/2 mice, but well
Figure 2. Lung and blood CFU from WT, TLR4
lps-d, TLR9
2/2, and TLR4
lps-d/TLR9
2/2 mice 24 hrs and 48 hrs post i.t. Klebsiella
challenge. Mice were given 5610
2 CFU Klebsiella i.t., lungs and blood harvested at designated time points and CFU assessed. Panel A shows lung
and blood CFU at 24 hrs and panel B is lung and blood CFU at 48 hrs post i.t. Klebsiella challenge. CFU are expressed in mean log10 6 SEM. n=628,
*p ,0.05 as compared to WT mice, # p,0.01 as compared to single mutants, {,0.05 as compared to TLR9
2/2 mice.
doi:10.1371/journal.pone.0009896.g002
Toll Receptors in Pneumonia
PLoS ONE | www.plosone.org 4 March 2010 | Volume 5 | Issue 3 | e9896maintained in TLR4 single mutant mice. As compared to infected
WT mice, the production of IL-17 was moderately reduced in
both TLR4
lps-d and TLR9
2/2 mice (p,0.05), and was nearly
completely extinguished in the lungs of TLR4
lps-d/TLR9
2/2
double mutant mice.
IL-17 expression by CD4+ T cells and cd T cells in WT,
TLR4
lps-d, TLR9
2/2 and TLR4
lps-d/TLR9
2/2 double mutant
mice after K. pneumoniae administration
To determine which cells were responsible for reduced IL-17
production in mutant mice during bacterial pneumonia, we
performed flow cytometry to quantitated the number and % of
CD4+ T cells and cd T cells expressing intracellular IL-17 in WT,
TLR4
lps-d, TLR9
2/2 and TLR4
lps-d/TLR9
2/2 double mutant
mice 24 hours post i.t. Klebsiella challenge. We focused on CD4+ T
cells and cd T cells, as these cells are believed to be the major
cellular sources of IL-17 during lung bacterial infection [13,16]. As
shown in Figure 4, the % of CD4+ T cells expressing IL-17 was
low in the uninfected state (,1%). In WT mice, there was a .10-
fold increase in both the percentage and total number of cells co-
expressing CD4 and IL-17. As compared to WT infected animals,
the total number of CD4+/IL-17+ cells was decreased in infected
TLR4
lps-d, TLR9
2/2 and TLR4
lps-d/TLR9
2/2 double mutant
mice by 51, 56, and 68% respectively. The percentage of cd T
cells expressing IL-17 in WT infected mice was considerably
higher than the percentage of CD4+ T cells. Similar to CD4+ T
cells, the % and total number of IL-17+ cd T cells was reduced in
TLR4
lps-d, TLR9
2/2 and most notably TLR4
lps-d/TLR9
2/2
double mutant mice. (26, 24 and 21%, respectively). These
findings indicate that both TLR4 and TLR9 contribute to IL-17
production from CD4+ T cells and cdT cells during bacterial
pneumonia.
IL-23 production in-vivo and from bone marrow derived
dendritic cells (BMDC) isolated from WT and TLR mutant
mice in-vitro in response to K. pneumoniae
The previous studies demonstrate reduced expression of IL-17
from TLR single and double mutant mice. As IL-23 is a strong
endogenous inducer of IL-17 [13,17], we next assessed the K.
pneumoniae-induced expression of IL-23 in WT and mutant mice
in-vivo and from BMDC in-vitro. As shown in Figure 5A, whole
lung levels of IL-23 peaked in WT mice at 6 hrs post bacterial
administration, returning toward baseline by 24 hrs. Maximum
IL-23 production was significanly diminished in TLR4
lps-d and
TLR9
2/2 single mutant mice, and nearly completely mitigated in
infected TLR4
lps-d/TLR9
2/2 double mutant mice. To determine
if reduced IL-23 responses were attributable to impaired
production of IL-23 by DC, we isolated BMDC from WT, single,
and double mutant mice, incubated cells (5610
5/ml) with vehicle
or heat killed K. pneumoniae (10:1 MOI), then assessed for IL-23
secretion 16 hrs later. As compared to vehicle-exposed control
cells, incubation with bacteria resulted in a 27-fold increase in IL-
23 levels (Figure 5B). Importantly, production of IL-23 by K.
pneumoniae-exposed BMDC isolated from TLR4
lps-d or TLR9
2/2
mice was reduced by 31 and 48%, as compared to WT DC
(p=0.08 and ,0.01, respectively). Moreover, IL-23 production by
BMDC isolated from TLR4
lps-d/TLR9
2/2 double mutant mice
was dramatically reduced, as compared to BMDC from WT and
single mutant animals (p,0.05 for all groups).
Ex-vivo lung macrophage phenotype in WT, TLR4
lps-d,
TLR9
2/2 and TLR4
lps-d/TLR9
2/2 double mutant mice after
K. pneumoniae administration
We next assessed the activational status of lung macrophages
isolated from WT and mutant mice 24 hrs after intrapulmonary
bacterial challenge. The state of macrophage activation was
determined by mRNA expression of iNOS as a marker of classical
activation (M1) and Fizz-1 as a marker of alternative activation
(M2). Alveolar macrophages were isolated from BAL ex-vivo by
adherence purification, then constitutive expression of iNOS
(NOS2) and Fizz-1 assessed by realtime quantitative PCR. As
shown in Figure 6, Klebsiella infection in WT mice resulted in a
marked upregulation of iNOS mRNA expression in lung
macrophages (37-fold increase over uninfected controls). The
expression of iNOS was partially reduced in lung macrophages
from infected TLR4 single mutant mice, whereas the induction of
iNOS was nearly completely mitigated in lung macrophages from
TLR9
2/2 and TLR4
lps-d/TLR9
2/2 mice. Interestingly, induc-
tion of Fizz-1 was detected only in alveolar macrophages isolated
from infected TLR4
lps-d/TLR9
2/2 double mutant mice.
Intrapulmonary administration of IL-17 improves lung
and systemic bacterial clearance in TLR4
lps-d/TLR9
2/2
double mutant mice after K. pneumoniae challenge
To determine if the defect in IL-17 production contributed to
impaired host defense against K. pneumoniae intheTLR4
lps-d/TLR9
2/
2 double mutant mice, we performed rescue experiments using
recombinant murine IL-17 administered i.t. immediately after i.t.
Klebsiella challenge. Wildtype and TLR4
lps-d/TLR9
2/2 mice were
administered 8610
2 CFU Klebsiella followed sequentially by i.t. rm
IL-17A (1 mg) or vehicle, then blood and lungs harvested 24 hrs later.
As compared to WT animals, vehicle-treated TLR4
lps-d/TLR9
2/2
Table 1. Cell recruitment after i.t. Klebsiella challenge in WT and mutant mice.
Cell count WT/Un WT/kp TLR4
lps-d/kp TLR9
2/2/kp TLR4
lps-d9
2/2/kp
Total cells 1.260.26106 24.662.26106 24.261.36106 25.561.36106 24.262.56106
PMN 0.460.736106 8.261.326106 3.161.016106
* 8.961.16106 3.560.46106
*
Monocytes/Macrophages 0.860.46106 15.262.066106 21.262.066106 17.762.036106 21.563.036106
Total cells ND 32.361.36106 33.163.56106 31.263.36106 33.364.46106
PMN ND 16.260.36106 12.560.26106 14.861.046106 14.861.046106
Monocytes/Macrophages ND 16.162.036106 20.262.346106 16.661.156106 19.561.056106
Leukocytes were harvested from lung 6 and 24 hrs post Klebsiella administration by collagenase lung digest, and cytospins performed. *p,0.05 as compared to WT
mice. n=5 in each group. Un= untreated, ND= not done.
doi:10.1371/journal.pone.0009896.t001
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tissue and increased systemic dissemination, as measured by blood
CFU (Figure 7A). Treatment with IL-17 in WTmice resulted in a 21-
fold reduction in lung K. pneumoniae CFU. None of the WT mice
developed bacteremia. However, treatment of TLR4
lps-d/TLR9
2/2
mice with IL-17 resulted in a more substantial 156- and 215-fold
reduction of K. pneumoniae CFU in lung and blood, respectively
(p,0.01 for lung and p,0.001 for blood). Interleukin-17 has been
shown to induce neutrophil active CXC chemokines from lung
macrophages in pneumonia [15,18]. Interestingly, the i.t. adminis-
tration of IL-17 resulted in a 2- and 2.2-fold induction of KC/
CXCL1 and MIP-2/CXCL2 in infected TLR4
lps-d/TLR9
2/2 mice
(Figure 7B, p,0.05 and p=0.08, respectively), although treatment
with IL-17 failed to restore lung chemokines levels to that observed in
infected WT animals.
Discussion
Toll like receptors are responsible for innate recognition of
microbes. Previous studies have identified several TLRs,
including TLR4, TLR5, and TLR9 as active participants in
lung antibacterial immunity against extracellular Gram-nega-
tive bacterial pathogens [6,8,19]. While the contribution of
individual TLRs have been well described, the temporal
importance and potential interactions between TLRs during
bacterial infection has not been thoroughly investigated. Our
study indicates that TLR4 and TLR9 have both non-redundant
and complementary functions during the generation of
protective innate immunity. Moreover, we found that TLR4
and TLR9 regulate lung IL-23 and IL-17 responses in
pneumonia.
Figure 3. Cytokine production in whole lung after i.t. bacterial challenge. WT, TLR4
lps-d, TLR9
2/2, and TLR4
lps-d/TLR9
2/2 mice were
challenged with 5610
2 CFU Klebsiella, then lungs harvested 6 hrs and 24 hrs post bacterial challenge. Cytokine levels were measured by ELISA. n=5
in each group. *p,0.01 as compared to WT, # p,0.01 as compared to single mutant mice.
doi:10.1371/journal.pone.0009896.g003
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clearance in mice with defective TLR4 or deletion of TLR9
[8,14,20]. However, the greatest defect in lung bacterial clearance
was observed in TLR4
lps-d/TLR9
2/2 double mutant mice,
indicating that both TLR4 and TLR9 are required for optimal
clearance. The early influx of PMN was markedly reduced in
Klebsiella-infected TLR4
lps-d mice, which may be due to impaired
production of the neutrophil active chemokines [21]. Moreover,
TLR4 appears to drive the early production of the type 1
promoting cytokine IL-12. By comparison, defects in later
production (24 hrs) of IL-12 and expression of the activating
cytokine IFN-c was observed in TLR9 deficient mice after
bacterial challenge, consistent with the notion the TLR9 promotes
type 1 immunity during pneumonia. Importantly, both TLR4 and
TLR9 contribute to the production of TNF-a, IL-23 and IL-17,
and maximal expression of IL-17 responses appears to require
both of these TLRs.
Alterations in the lung cytokine milieu are a probable cause for
differential activation of pulmonary macrophages in mutant mice
during pneumonia. Impaired classical activation of macrophages
(as manifest by constitutive ex-vivo expression of iNOS) was
observed in cells from all mutant mouse strains post infection, but
most prominent in macrophages with defective TLR9 signaling
(either TLR9
2/2 or TLR4
lps-d/TLR9
2/2 cells). This is consistent
with our previous finding of impaired expression of iNOS and
nitric oxide by lung macrophages from Klebsiella-challenged
TLR9
2/2 mice, which was associated with reduced intracellular
bacterial killing but not phagocytic responses. IFN-c is a key driver
of classical macrophage activation [22], and the substantial
impairment in the production of this cytokine in TLR9 single or
double mutant mice corresponds with reduced iNOS expression.
Interestingly, the expression of Fizz-1 as a marker of alternative
activation or M2 phenotype [23,24] was found only in
macrophages from double mutant mice, suggesting that both
TLR4 and TLR9 are required to prevent alternative macrophage
activation during infection.
Differences in the expression of various cytokines in the TLR
mutant mice may be accounted for by cell-specific expression of
Figure 4. IL-17 expression by lung cd and CD4+ T cells after i.t. K. pneumoniae administration. Flow cytometric analysis showing the
number and percentage of cd (A) and CD4+ T cells (B) with intracellular IL-17, 24 hours after i.t. K. pneumoniae challenge. n=4 in each group.
*p,0.05 as compared to WT post i.t. K. pneumoniae.
doi:10.1371/journal.pone.0009896.g004
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minimal TLR9 [25], which may contribute to early production of
TNF-a and chemokines. Similarly, structural cells, including the
alveolar epithelium, express chemokines in response to both
PAMPs and host-derived cytokines elaborated by pulmonary
macrophages [26,27,28,29]. By comparison, TLR9 expressing
dendritic cells elaborate type 1 promoting cytokines that drive the
production of IFN-c from NK cells and T cells [8,30]. Our flow
cytometry studies indicate that cd-T cells, and to a lesser extent
CD4+ Th17 cells, are important sources of IL-17 during bacterial
pneumonia. Moreover, the production of IL-17 by these cells is
regulated by both TLR4 and TLR9. We cannot exclude direct
TLR stimulation of cd T cells by microbial products, as these cells
have been shown to respond in a TLR4 dependent fashion
[15,31,32,33]. However, our data indicates that impaired IL-17
production in TLR4 and TLR9 mutant mice may be attributable
to reduced IL-23 expression by DC and possibly other proximal
cells, as IL-23 is known to be a major paracrine inducer of IL-17 in
bacterial pneumonia [13,15,16] and we observed substantial
defects in lung IL-23 production from TLR4/9 double mutant
mice compared to infected WT animals. Impairment in the
elaboration of IL-17 in double mutant mice clearly contributes to
Figure 5. Expression of IL-23 in WT and mutant mice in-vivo and in-vitro. (A) Whole lung IL-23 production after i.t. K. pneumonia
administration. n=5 in each group. *p,0.05 as compared to WT post i.t. bacteria. (B) Secretion of IL-23 by BMDC incubated with heat killed K.
pneumoniae for 18 hrs. n=5 in each group. *p,0.01 as compared to WT BMDC; #p,0.05 as compared to single mutants.
doi:10.1371/journal.pone.0009896.g005
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bacterial clearance mechanisms in TLR4
lps-d/TLR9
2/2 mice.
While treatment with IL-17 resulted in some reconstitution of
CXC chemokine production, it is likely that full restoration of
chemokines was not achieved due to diminished TNF-a
expression, which has been shown to be required for optimal IL-
17 mediated induction of selected CXC chemokines [18].
Survival studies performed indicate that mortality in TLR4
lps-d
single mutant and TLR4
lps-d/TLR9
2/2 double mutant mice was
similar, despite more dramatic impairment in lung bacterial
clearance in the double mutant mice as compared the TLR4
lps-d
single mutant mice. This suggests that mortality in this model is
not completely dependent on efficacy of lung bacterial clearance.
One distinct possibility accounting for differences in mortality is
divergent roles of TLRs in regulating the magnitude lung injury.
To this end, we have found that TLR4
lps-d and TLR9
2/2 mice
display quite different patterns of lung injury in response to K.
pneumoniae challenge, as TLR4
lps-d mice develop substantial
alveolar leak (as measured by BAL albumin levels) as compared
to infected WT animals, whereas TLR9
2/2 mice tended to be
protected against lung injury as compared to WT mice (data not
shown). Our finding of enhanced lung injury in TLR4
lps-d mice is
consistent with the finding of increased lung injury in TLR4
deficient mice in response to intrapulmonary bleomycin admin-
istration or hyperoxic exposure [34,35]. The role of TLR9 in
regulating lung injury responses has not been reported but is a
focus of ongoing investigations in our laboratory. Increased lung
injury in TLR4
lps-d single mutant mice may also account for
increased systemic dissemination in these animals relative to lung
bacterial burden.
Collectively our study shows for the first time that TLR4 and
TLR9 have distinct time-dependent and interactive functions
Figure 6. Expression of iNOS and FIZZ by alveolar macrophages. WT, TLR4
lps-d, TLR9
2/2, and TLR4
lps-d/TLR9
2/2 mice were challenged with
5610
2 CFU Klebsiella i.t. and BAL performed at 24 hours. Alveolar macrophages were harvested by adherence purification and iNOS and Fizz
expression measured by RT-PCR. n=5 in each group. *p,0.01 as compared to WT, {,0.05 as compared to TLR9
2/2 mice.
doi:10.1371/journal.pone.0009896.g006
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immunity in the lung. Modulation of TLR-mediated responses
may represent an important target of therapy in patients with
severe bacterial infection of the respiratory tract.
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